Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Stephens

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
Genes, Chromosomes & Cancer|August 21, 2010
Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumorsDavid J McBride, Arto K Orpana, Christos Sotiriou, et al.
The Oncologist|February 18, 2017
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase FusionsPierre Vanden Borre, Alexa B Schrock, Peter M Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or AnusAlexa B Schrock, Dean Pavlick, Samuel J Klempner, et al.
The Oncologist|April 18, 2015
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapiesSiraj M Ali, Eric M Sanford, Samuel J Klempner, et al.
The Oncologist|February 25, 2014
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencingJeffrey S Ross, Kai Wang, Laurie Gay, et al.
The American Journal of Surgical Pathology|January 15, 2014
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapiesJeffrey S Ross, Kai Wang, Janna V Rand, et al.
Journal of Hematology & Oncology|June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusionVivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
Cancer|October 20, 2015
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapiesRami N Al-Rohil, Ashley J Tarasen, J Andrew Carlson, et al.
Cancer Cell|March 22, 2016
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2Scott A Foster, Daniel M Whalen, Ayşegül Özen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLCJonathan W Riess, David R Gandara, Garrett M Frampton, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Genes, Chromosomes & Cancer|August 21, 2010
Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumorsDavid J McBride, Arto K Orpana, Christos Sotiriou, et al.
The Oncologist|February 18, 2017
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase FusionsPierre Vanden Borre, Alexa B Schrock, Peter M Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or AnusAlexa B Schrock, Dean Pavlick, Samuel J Klempner, et al.
The Oncologist|April 18, 2015
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapiesSiraj M Ali, Eric M Sanford, Samuel J Klempner, et al.
The Oncologist|February 25, 2014
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencingJeffrey S Ross, Kai Wang, Laurie Gay, et al.
The American Journal of Surgical Pathology|January 15, 2014
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapiesJeffrey S Ross, Kai Wang, Janna V Rand, et al.
Journal of Hematology & Oncology|June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusionVivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
Cancer|October 20, 2015
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapiesRami N Al-Rohil, Ashley J Tarasen, J Andrew Carlson, et al.
Cancer Cell|March 22, 2016
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2Scott A Foster, Daniel M Whalen, Ayşegül Özen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLCJonathan W Riess, David R Gandara, Garrett M Frampton, et al.
Pageof 17